Investment
Features
FeesSafety
Academy
More
Pluang+

Thailand allows crypto ETFs to invest only in Bitcoin and Ether starting Oct 16

Market News
08 Oct 2026
Tokenpost
View Source
Neutral
Thailand allows crypto ETFs to invest only in Bitcoin and Ether starting Oct 16

Thailand's Securities and Exchange Commission will permit crypto exchange-traded funds (ETFs) to invest exclusively in Bitcoin and Ether under new regulations effective from October 16. The SEC introduced 11 rules requiring funds to use passive strategies, maintain at least 80% net exposure to a single crypto asset annually, and hold assets with regulated custodians. The framework also enables Thai mutual and private funds to invest in domestic crypto ETFs, expanding access beyond direct crypto holdings. Brokerages are prohibited from financing crypto ETF purchases and offering overseas crypto ETF services to most retail investors during the initial phase, limiting such services to institutional and ultra-high-net-worth clients only.

Thailand's new crypto ETF rules come with this market snapshot from Pluang as of Oct 09, 2026 09:41 WIB: Out of 50 major cryptocurrencies priced on Pluang, 9 rose and 40 fell today. Notable movers include AVAX at Rp183.642 with a 7.31% decline and a typical hold time of 87 days, XTZ at Rp5.179 down 6.47% but with 100% buy order activity, and SOL at Rp1.962.403 down 5.65% with 68% buy order activity.

More News

Sigenergy debuts AI-powered energy solutions and new partnerships at Malaysia's IGEM 2026.

Sigenergy debuts AI-powered energy solutions and new partnerships at Malaysia's IGEM 2026.

At Malaysia's IGEM 2026, Sigenergy showcased its latest AI-driven energy technologies, including smart storage and inverter systems, highlighting its role in advancing sustainable energy. The company also signed MOUs with local partners Milieu and YT...

Market News
Bullish
2 hours ago
Entrada Therapeutics rated Buy with $8.50 target, expects higher drug dosing results in 2027.

Entrada Therapeutics rated Buy with $8.50 target, expects higher drug dosing results in 2027.

Entrada Therapeutics is rated Buy with a fair value of $8.50, implying about 52% upside from the current $5.61 price. The company’s Duchenne muscular dystrophy drug ENTR-601-44 showed a disappointing initial increase in dystrophin, but this is attrib...

Analyst Insights
Neutral
4 hours ago
Ten-year Treasury yields hit 5.36% amid systemic debt concerns and strong stock market gains.

Ten-year Treasury yields hit 5.36% amid systemic debt concerns and strong stock market gains.

Ten-year U.S. Treasury yields reached 5.36% intraday, reflecting growing systemic sovereign debt issues. Despite these concerns, the stock market showed strength with the S&P 500 rising 1.2% and the Dow gaining 0.9%, supported by a 43-week expansion ...

Market News
Neutral
4 hours ago
Pump.fun's token buyback drops as daily revenue falls 16%, impacting price support until April 2027.

Pump.fun's token buyback drops as daily revenue falls 16%, impacting price support until April 2027.

Pump.fun's daily revenue, which funds half of its token buyback and burn program, fell 16% from $1.89 million on October 5 to $1.59 million on October 9, causing the token price to drop 16.8% from its weekly high. The buyback program, running until A...

Protocol Fundamentals
Bearish
4 hours ago
Alphamin Resources offers a promising buy with stable tin mines and growth potential in DRC.

Alphamin Resources offers a promising buy with stable tin mines and growth potential in DRC.

Alphamin Resources Corp. operates two profitable tin mines in the Democratic Republic of Congo and is focusing on exploration around its Bisie resource, offering speculative growth potential. The company's current operations are stable and profitable...

Analyst Insights
Bullish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App